The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2018Analysis of the LRRK2-Rab Signaling Pathway
Promising Outcomes of Original Grant:
The highlight of our teams' recent MJFF funded research has been the discovery of the key physiological targets of LRRK2 that comprise a group of proteins termed... -
Research Grant, 2018Analyzing Parkinson’s Data with the Razor Platform for Hypothesis Generation and Scientific Decision-making
Study Rationale:
Experts from various biomedical fields are trying to identify treatment options for Parkinson's disease, but approaches that target a single gene or mechanism have thus far been... -
Research Grant, 2018Genetic Factors that Influence Inherited Parkinson's Disease Associated with Changes in the GBA gene
Study Rationale:
Changes (variants) in the GBA gene are among the most common genetic factors that affect the risk of developing Parkinson's disease (PD). Individuals who carry the same GBA variants... -
Research Grant, 2018The Role of Lysosomal Proteins in Inherited Parkinson's Disease Associated with Changes in the GBA gene
Study Rationale:
Changes (mutations) in the GBA gene are among the most common and important genetic factors leading to Parkinson's disease (PD). The GBA gene directs the production of the... -
iPD Program, 2018Impact of Genetic Changes Linked to Both Crohn's Disease and Parkinson's Disease on the LRRK2 Protein
Study Rationale:
Recent research suggests an about 30 percent higher rate of Parkinson's disease (PD) in people with Crohn's disease (CD) than in those without CD. This could be, at least in part... -
Research Grant, 2018Nanoparticles for Detecting Parkinson's Disease Hallmarks with Magnetic Resonance Imaging
Study Rationale:
There is currently no effective imaging agent -- a chemical that reveals signs of disease -- that allows physicians to diagnose Parkinson's disease (PD) at an early stage, to monitor...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.